BONNIE HILL: Open Payments
NPI 1538585385 · LOUISA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107,937 in 262 payments from 13 companies in 2025. Trend: 2023 $67,662 · 2024 $89,232 · 2025 $107,937
Speaker / faculty: $69,540Travel & lodging: $16,431Consulting: $16,378Food & beverage: $5,504Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 134 | $70,791 |
| Madrigal Pharmaceuticals | 48 | $22,759 |
| Aimmune Therapeutics, Inc. | 24 | $8,006 |
| EVOKE PHARMA, INC. | 11 | $5,497 |
| Janssen Biotech, Inc. | 18 | $428 |
| Phathom Pharmaceuticals, Inc. | 12 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Novo Nordisk Inc | 2 | $49 |
| Ardelyx, Inc. | 2 | $42 |
Products named: MAVYRET, REZDIFFRA, ZENPEP, GIMOTI, TREMFYA, RINVOQ, QULIPTA, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
